A trial in healthy participants to examine the safety, tolerability, and pharmacokinetics of orally administered FT751

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519998-19-00

Acronym

FT751-1001

Enrollment

120

Registered

2025-03-06

Start date

2025-03-14

Completion date

Unknown

Last updated

2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory diseases

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026